sea-bcma
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 22, 2018 (NCT03266692)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594496 ↗
Also known as
- sea-bcma
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03582033 | Phase 1 | Sep 30, 2018 | Seattle Genetics |
| NCT03266692 | Phase 1 | Feb 22, 2018 | Cogent Biosciences, Seattle Genetics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seattle Genetics | For profit | 2 | 1 | 1 | 2018 |
| Cogent Biosciences | For profit | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1